Personal information

Other IDs

Scopus Author ID: 35760567300

Activities

Collapse all

Employment (3)

University of Minnesota Physicians: Minneapolis, MN, US

2010-08-01 to present | Oncology (Medicine)
Employment
Source: Self-asserted source
Manish Patel

Winthrop-University Hospital: Mineola, New York, US

2004-07-01 to 2005-06-18 | Research Fellow (Medicine)
Employment
Source: Self-asserted source
Manish Patel

Northwestern University Northwestern University Health Service Evanston: Evanston, IL, US

2001-07-01 to 2004-06-21 | Resident (Medicine)
Employment
Source: Self-asserted source
Manish Patel

Education and qualifications (2)

Kirksville College of Osteopathic Medicine: Kirksville, MO, US

1997-08-16 to 2001-06-18 | DO
Education
Source: Self-asserted source
Manish Patel

Vanderbilt University: Nashville, TN, US

1992-08-26 to 1996-05-06 | BS (molecular biology)
Education
Source: Self-asserted source
Manish Patel

Works (48)

Improving Patient Understanding and Outcomes in Lung Cancer Using an Animated Patient’s Guide with Visual Formats of Learning

Journal of Cancer Education
2024-10-22 | Journal article
DOI: 10.1007/s13187-024-02517-7
Contributors: Manish R. Patel; Abbie Begnaud; Shanda H. Blackmon; Arkadiusz Z. Dudek; Naomi Fujioka; Janine C. K. Harewood; Pasi A. Jänne; Shirley Kern; Lacey Running Hawk; Ann M. Rusk et al.
Source: check_circle
Crossref

Data from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6532467
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Data from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6532467.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Data from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487232
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Data from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487232.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487211
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487223
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487226
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487229
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487217
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487214
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487220
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487208
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487208.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487214.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487217.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487223.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487226.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487229.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487220.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Supplementary Figure from Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With <i>NTRK</i> Fusion-Positive Solid Tumors

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22487211.v1
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Clinical Cancer Research
2022-04-01 | Journal article
DOI: 10.1158/1078-0432.CCR-21-3597
Contributors: George D. Demetri; Filippo De Braud; Alexander Drilon; Salvatore Siena; Manish R. Patel; Byoung Chul Cho; Stephen V. Liu; Myung-Ju Ahn; Chao-Hua Chiu; Jessica J. Lin et al.
Source: check_circle
Crossref

Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer

Clinical Medicine Insights: Oncology
2021-01 | Journal article
DOI: 10.1177/11795549211004489
Contributors: Shijia Zhang; Daniel F Pease; Amit A Kulkarni; Manoj Kumar; Ryan M Shanley; Beibei Xu; Shilvi P Joshi; Manish R Patel
Source: check_circle
Crossref

A review of avelumab in locally advanced and metastatic bladder cancer

Therapeutic Advances in Urology
2019-01 | Journal article
DOI: 10.1177/1756287218823485
Contributors: Arpit Rao; Manish R. Patel
Source: check_circle
Crossref

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

Investigational New Drugs
2017 | Journal article
DOI: 10.1007/s10637-017-0535-z
EID:

2-s2.0-85033402695
Contributors: De, A.; Jacobson, B.A.; Peterson, M.S.; Jay-Dixon, J.; Kratzke, M.G.; Sadiq, A.A.; Patel, M.R.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma

Oncotarget
2017 | Journal article
DOI: 10.18632/oncotarget.18656
EID:

2-s2.0-85021361162
Contributors: Jacobson, B.A.; Sadiq, A.A.; Tang, S.; Jay-Dixon, J.; Patel, M.R.; Drees, J.; Sorenson, B.S.; Russell, S.J.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Viroimmunotherapy of thoracic cancers

Biomedicines
2017 | Journal article
DOI: 10.3390/biomedicines5010002
EID:

2-s2.0-85035339621
Contributors: Dash, A.S.; Patel, M.R.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy- a report of two cases

Journal for ImmunoTherapy of Cancer
2016 | Journal article
DOI: 10.1186/s40425-016-0185-2
EID:

2-s2.0-84997724774
Contributors: Kolla, B.C.; Patel, M.R.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells

Cancer Gene Therapy
2015 | Journal article
DOI: 10.1038/cgt.2015.34
EID:

2-s2.0-84939470549
Contributors: Thumma, S.C.; Jacobson, B.A.; Patel, M.R.; Konicek, B.W.; Franklin, M.J.; Jay-Dixon, J.; Sadiq, A.; De, A.; Graff, J.R.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Endometrial metastasis of lung adenocarcinoma: A report of two cases

American Journal of Case Reports
2015 | Journal article
DOI: 10.12659/AJCR.892495
EID:

2-s2.0-84935851204
Contributors: Ahmad, Z.; Raza, A.; Patel, M.R.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Targeting topoisomerase II activity in NSCLC with 9-aminoacridine derivatives

Anticancer Research
2015 | Journal article
EID:

2-s2.0-84942770905
Contributors: Ferguson, D.M.; Jacobson, B.A.; Jay-Dixon, J.; Patel, M.R.; Kratzke, R.A.; Raza, A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma

Genes and Cancer
2015 | Journal article
EID:

2-s2.0-84949551926
Contributors: Jacobson, B.A.; Chen, E.Z.; Tang, S.; Belgum, H.S.; McCauley, J.A.; Evenson, K.A.; Etchison, R.G.; Jay-Dixon, J.; Patel, M.R.; Raza, A. et al.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Oncotarget
2015 | Journal article
DOI: 10.18632/oncotarget.5320
EID:

2-s2.0-84946075900
Contributors: Patel, M.R.; Jacobson, B.A.; Ji, Y.; Drees, J.; Tang, S.; Xiong, K.; Wang, H.; Prigge, J.E.; Dash, A.S.; Kratzke, A.K. et al.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

An absolute obstacle: Cardiac metastasis of synovial sarcoma

American Journal of Medicine
2014 | Journal article
DOI: 10.1016/j.amjmed.2014.01.005
EID:

2-s2.0-84898957095
Contributors: Vakil, K.; Raza, A.; Zakharova, M.; Madlon-Kay, R.; Skubitz, K.; Patel, M.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Genetic Engineering of Oncolytic Viruses for Cancer Therapy

Translating Gene Therapy to the Clinic: Techniques and Approaches
2014 | Book
DOI: 10.1016/B978-0-12-800563-7.00017-8
EID:

2-s2.0-84944385437
Contributors: Patel, M.R.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Measles vaccine strains for virotherapy of non-small-cell lung carcinoma

Journal of Thoracic Oncology
2014 | Journal article
DOI: 10.1097/JTO.0000000000000214
EID:

2-s2.0-84905823230
Contributors: Patel, M.R.; Jacobson, B.A.; Belgum, H.; Raza, A.; Sadiq, A.; Drees, J.; Wang, H.; Jay-Dixon, J.; Etchison, R.; Federspiel, M.J. et al.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells

Investigational New Drugs
2014 | Journal article
DOI: 10.1007/s10637-014-0076-7
EID:

2-s2.0-84904556518
Contributors: Chen, E.Z.; Jacobson, B.A.; Patel, M.R.; Okon, A.M.; Li, S.; Xiong, K.; Vaidya, A.J.; Bitterman, P.B.; Wagner, C.R.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Oncolytic virus therapy for cancer: The first wave of translational clinical trials

Translational Research
2013 | Journal article
DOI: 10.1016/j.trsl.2012.12.010
EID:

2-s2.0-84875182214
Contributors: Patel, M.R.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Resistance to EGFR-TKI can be mediated through multiple signaling pathways converging upon cap-dependent translation in EGFR-wild type NSCLC

Journal of Thoracic Oncology
2013 | Journal article
DOI: 10.1097/JTO.0b013e31829ce963
EID:

2-s2.0-84883453155
Contributors: Patel, M.R.; Jay-Dixon, J.; Sadiq, A.A.; Jacobson, B.A.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide

PLoS ONE
2013 | Journal article
DOI: 10.1371/journal.pone.0081669
EID:

2-s2.0-84894136566
Contributors: Jacobson, B.A.; Thumma, S.C.; Jay-Dixon, J.; Patel, M.R.; Dubear Kroening, K.; Kratzke, M.G.; Etchison, R.G.; Konicek, B.W.; Graff, J.R.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis

Investigational New Drugs
2012 | Journal article
DOI: 10.1007/s10637-011-9720-7
EID:

2-s2.0-84866728317
Contributors: Raza, A.; Jacobson, B.A.; Benoit, A.; Patel, M.R.; Jay-Dixon, J.; Hiasa, H.; Ferguson, D.M.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation

International Journal of Oncology
2012 | Journal article
DOI: 10.3892/ijo.2011.1252
EID:

2-s2.0-84855649801
Contributors: Patel, M.R.; Sadiq, A.A.; Jay-Dixon, J.; Jirakulaporn, T.; Jacobson, B.A.; Farassati, F.; Bitterman, P.B.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues

Archives of Pathology and Laboratory Medicine
2011 | Journal article
EID:

2-s2.0-79952961510
Contributors: Kodali, D.; Rawal, A.; Ninan, M.J.; Patel, M.R.; Mesa, H.; Knapp, D.; Schnitzer, B.; Kratzke, R.A.; Gupta, P.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II

Investigational New Drugs
2010 | Journal article
DOI: 10.1007/s10637-008-9209-1
EID:

2-s2.0-74149092112
Contributors: Sadiq, A.A.; Patel, M.R.; Jacobson, B.A.; Escobedo, M.; Ellis, K.; Oppegard, L.M.; Hiasa, H.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma

British Journal of Cancer
2009 | Journal article
DOI: 10.1038/sj.bjc.6605184
EID:

2-s2.0-68149161618
Contributors: Jacobson, B.A.; De, A.; Kratzke, M.G.; Patel, M.R.; Jay-Dixon, J.; Whitson, B.A.; Sadiq, A.A.; Bitterman, P.B.; Polunovsky, V.A.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration

American Journal of Clinical Nutrition
2008 | Journal article
EID:

2-s2.0-45749139546
Contributors: Aloia, J.F.; Patel, M.; DiMaano, R.; Li-Ng, M.; Talwar, S.A.; Mikhail, M.; Pollack, S.; Yeh, J.K.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Ras pathway activation in malignant mesothelioma

Journal of Thoracic Oncology
2007 | Journal article
DOI: 10.1097/JTO.0b013e31811f3aab
EID:

2-s2.0-34548391771
Contributors: Patel, M.R.; Jacobson, B.A.; De, A.; Frizelle, S.P.; Janne, P.; Thumma, S.C.; Whitson, B.A.; Farassati, F.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier

Effects of Insulin-Like Growth Factor-1 Receptor Inhibition in Mesothelioma

Annals of Thoracic Surgery
2006 | Journal article
DOI: 10.1016/j.athoracsur.2006.04.013
EID:

2-s2.0-33747371111
Contributors: Whitson, B.A.; Jacobson, B.A.; Frizelle, S.; Patel, M.R.; Yee, D.; Maddaus, M.A.; Kratzke, R.A.
Source: Self-asserted source
Manish Patel via Scopus - Elsevier
How many people are using ORCID?